Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00189436 · ClinicalTrials.gov registry record · Phase 4
Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children
A Phase 4 study of Asthma, sponsored by Deborah Gentile.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
- 2
- Study locations
NCT00189436 is a Phase 4 study of Asthma that has completed, run by Deborah Gentile. The registered enrollment target is 61 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00189436, a Phase 4 study of Asthma, has completed, sponsored by Deborah Gentile.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
- 2
- Study locations
Study Summary
Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.
Conditions Studied
Interventions
- DRUG Nebulized Budesonide
- DRUG Usual care (albuterol with or without oral steroid)
Study Locations (2)
Pennsylvania
- Bellevue Pediatric Associates - Bellevue
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2003-03 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00189436
The ClinicalTrials.gov registry entry for NCT00189436 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The listed sponsor is Deborah Gentile, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Nebulized Budesonide is the first listed.
NCT00189436 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00189436 about?
NCT00189436 is a clinical study titled "Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children". Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide a...
What is the current status of trial NCT00189436?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2003-03. Estimated completion is 2009-01.
What conditions does trial NCT00189436 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00189436?
The interventions under investigation include: Nebulized Budesonide (DRUG), Usual care (albuterol with or without oral steroid) (DRUG).
Who is sponsoring clinical trial NCT00189436?
This trial is sponsored by Deborah Gentile, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00189436 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.